MarginsXMarginsX
Home › Data Desk › In depth: Alumis Inc. flags going-concern doubt in its 10-Q

MarginsX Data Desk · Daily feature · Going-concern doubt · Late-stage clinical trials · FDA approval · Early-stage clinical trials

In depth: Alumis Inc. flags going-concern doubt in its 10-Q

Alumis Inc. (ALMS) reported substantial doubt, in its 10-Q filed Nov 12, 2026, about whether it can keep operating as a going concern. (SEC EDGAR, 10-Q, 2026-11-12)

By the MarginsX Data Desk, automated. Published November 15, 2026. Data as of November 12, 2026.

Line chart of Alumis Inc. (ALMS) daily closes from Jul 6, 2026 to Nov 12, 2026, with the going-concern filing on Nov 12, 2026 marked.

By our estimate from its cash flows, the cash it reported covers about 2.2 months of spending at its recent rate. (Company health, computed by us from SEC filings and XBRL, 2026-09-30)

The filing

In the filing's own words, there is “substantial doubt about the Company's ability to conti”. Its previous periodic report, the 10-Q filed Aug 13, 2026, did not match EDGAR full-text search for going-concern language when we last ran it on Nov 14, 2026. The report covers the quarter to Sep 30, 2026 and was filed 43 days after it closed. Since its close of $6.13 on Nov 12, 2026, the day of the filing, the stock has lost 8.6%. (SEC EDGAR, 10-Q, 2026-11-12)

The numbers

Revenue for the three months to Sep 30, 2026 was $1.9M, down from $2.1M in the same quarter a year before, a fall of 7.7%. Its net loss narrowed to $94.9M, from $110.8M a year earlier. Its operations used $79.6M of cash. It ended the quarter with $57.7M in cash, against $65.3M a year earlier, and no debt on its balance sheet. Its current assets of $442.6M compare with current liabilities of $79.4M. Shareholders' equity stood at $378.4M, against $384.8M a year earlier. At its recent quarterly burn of $80.0M, we estimate that cash lasts about 2.2 months. (SEC XBRL company facts, 10-Q, 2026-11-12)

Against its own record

The shares last closed at $5.60 on Nov 13, 2026, 81.5% below their high of the past year, $30.30. That is close to the year's low of $5.52. Over three months the shares are down 77.1%, and over the year up 6.1%. The combined net loss over those four quarters was $423.1M. It has filed 2 prospectus takedowns under its shelf registration in the past year. The Data Desk last wrote about the company on Nov 14, 2026, under the headline “Alumis Inc. flags going-concern doubt in its 10-Q”. (Daily closes (Yahoo Finance chart endpoint), 2026-11-13)

Next to its peers

Its nearest neighbours by market value in pharmaceutical preparations are Ironwood Pharmaceuticals Inc. (IRWD), Ardelyx Inc. (ARDX), Lexicon Pharmaceuticals Inc. (LXRX), Sagimet Biosciences Inc. Series A (SGMT) and Collegium Pharmaceutical Inc. (COLL). Their median one-year return was +24.3%, against +6.1% for ALMS, which leaves it behind the middle of the group. The range runs from Ironwood Pharmaceuticals Inc. (IRWD), at +43.3%, to Ardelyx Inc. (ARDX), at −47.0%. At $727.0M, its market value is the smallest of the group. By the same cash estimate, 1 of those 3 also have less than a year of cash at their recent burn. (MarginsX market map (industries from SEC and the Nasdaq screener), 2026-11-15)

Who else it touches

BlackRock, Inc. reported holding 5.7% of the shares in a Schedule 13G filed Jul 27, 2026. In a Schedule 13D/A filed Jul 2, 2026, AyurMaya Capital Management Company, LP reported 12.3%. In a Schedule 13G filed Apr 7, 2026, Deep Track Capital, LP reported 6.0%. Its officers and directors bought $38.0M and sold $1.5M of stock in the open market over the twelve months through Sep 30, 2026. On the latest quarterly holdings reports that institutional managers file with the SEC, 131 managers held the stock; the largest were BlackRock, Inc., with 8.6 million shares; Vanguard Capital Management LLC, with 4.3 million shares; and State Street Corp, with 2.9 million shares. Over that quarter, 47 of them added to their positions and 35 cut them. (SEC EDGAR, SCHEDULE 13G, 2026-07-27)

What to watch

Its 10-K for the period ending Dec 31, 2026 falls due by Wednesday, March 31, 2027 at the latest, the SEC's deadline of 90 days for non-accelerated filers; larger filers have less time. (SEC, Form 10-K general instructions, 2026-11-15)

By our estimate, the cash on hand at Sep 30, 2026 runs out around Dec 6, 2026 at the recent burn, before the 10-K is due. The 10-K will be the first report to show how far the cash went. (SEC XBRL company facts, 10-Q, 2026-11-12)

Written by the MarginsX Data Desk's template engine from SEC filings and market data, with no AI. Every figure is in the table of facts with its source. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameAlumis Inc.Source2026-11-13
Form10-QSource2026-11-12
WhoAlumis Inc. (ALMS)Source2026-11-13
SymbolALMSSource2026-11-13
FiledNov 12, 2026Source2026-11-12
Runway2.2 monthsSource2026-09-30
Gc phrasesubstantial doubt about the Company's ability to contiSource2026-11-12
Prev form10-QSource2026-08-13
Prev filedAug 13, 2026Source2026-08-13
Fts checkedNov 14, 2026Source2026-11-14
Q endSep 30, 2026Source2026-11-12
Filed days after43Source2026-11-12
Filed close6.13 USDSource2026-11-12
Filed close dayNov 12, 2026Source2026-11-12
Since filed0.086 %Source2026-11-13
M close5.6 USDSource2026-11-13
Q revenue1,907,000 USDSource2026-11-12
Q revenue a year earlier2,066,000 USDSource2026-11-12
Q revenue chg0.077 %Source2026-11-12
Q net loss94,881,000 USDSource2026-11-12
Q net income-94,881,000 USDSource2026-11-12
Q net loss a year earlier110,752,000 USDSource2026-11-12
Q net income a year earlier-110,752,000 USDSource2026-11-12
Q ocf abs79,571,000 USDSource2026-11-12
Q ocf-79,571,000 USDSource2026-11-12
Q cash57,691,000 USDSource2026-11-12
Q cash a year earlier65,257,000 USDSource2026-11-12
Q current assets442,590,000 USDSource2026-11-12
Q current liabilities79,405,000 USDSource2026-11-12
Q equity378,425,000 USDSource2026-11-12
Q equity a year earlier384,773,000 USDSource2026-11-12
Burn abs80,015,000 USDSource2026-09-30
Burn-80,015,000 USDSource2026-09-30
M dayNov 13, 2026Source2026-11-13
Below high0.815 %Source2026-11-13
High 52w30.3 USDSource2026-11-13
Low 52w5.52 USDSource2026-11-13
R3m abs0.771 %Source2026-11-13
R 3m-0.771 %Source2026-11-13
R1y abs20.061 %Source2026-11-13
R 1y0.061 %Source2026-11-13
Ttm loss423,086,000 USDSource2026-11-12
Ttm net income-423,086,000 USDSource2026-11-12
Takedowns 12m2Source2026-01-08
Prior dayNov 14, 2026Source2026-11-14
Prior titleAlumis Inc. flags going-concern doubt in its 10-QSource2026-11-14
Industrypharmaceutical preparationsSource2026-11-15
Peer namesIronwood Pharmaceuticals Inc. (IRWD), Ardelyx Inc. (ARDX), LSource2026-11-13
WhoIronwood Pharmaceuticals Inc. (IRWD)Source2026-11-13
NameIronwood Pharmaceuticals Inc.Source2026-11-13
SymbolIRWDSource2026-11-13
WhoArdelyx Inc. (ARDX)Source2026-11-13
NameArdelyx Inc.Source2026-11-13
SymbolARDXSource2026-11-13
WhoLexicon Pharmaceuticals Inc. (LXRX)Source2026-11-13
NameLexicon Pharmaceuticals Inc.Source2026-11-13
SymbolLXRXSource2026-11-13
WhoSagimet Biosciences Inc. Series A (SGMT)Source2026-11-13
NameSagimet Biosciences Inc. Series ASource2026-11-13
SymbolSGMTSource2026-11-13
WhoCollegium Pharmaceutical Inc. (COLL)Source2026-11-13
NameCollegium Pharmaceutical Inc.Source2026-11-13
SymbolCOLLSource2026-11-13
Peer median 1y0.243 %Source2026-11-13
R 1y0.433 %Source2026-11-13
R 1y-0.47 %Source2026-11-13
R 1y0.243 %Source2026-11-13
R 1y0.32 %Source2026-11-13
R 1y-0.454 %Source2026-11-13
Cap726,997,432 USDSource2026-11-13
Peers short cash1Source2026-09-30
Runway35.8 monthsSource2026-09-30
Runway10.7 monthsSource2026-09-30
Runway30.5 monthsSource2026-09-30
Peers with runway3Source2026-09-30
Holder 0BlackRock, Inc.Source2026-07-27
Holder pct 05.7 %Source2026-07-27
Holder form 0Schedule 13GSource2026-07-27
Holder filed 0Jul 27, 2026Source2026-07-27
Holder form 1Schedule 13D/ASource2026-07-02
Holder filed 1Jul 2, 2026Source2026-07-02
Holder 1AyurMaya Capital Management Company, LPSource2026-07-02
Holder pct 112.3 %Source2026-07-02
Holder form 2Schedule 13GSource2026-04-07
Holder filed 2Apr 7, 2026Source2026-04-07
Holder 2Deep Track Capital, LPSource2026-04-07
Holder pct 25.98 %Source2026-04-07
Insider buy 12m37,965,463.01 USDSource2026-09-30
Insider sell 12m1,548,492.66 USDSource2026-09-30
Insider throughSep 30, 2026Source2026-09-30
H13f n131Source2026-09-30
H13f shares 08,578,404 sharesSource2026-09-30
H13f shares 14,257,458 sharesSource2026-09-30
H13f shares 22,948,309 sharesSource2026-09-30
H13f listBlackRock, Inc., with 8.6 million shares; Vanguard Capital MSource2026-09-30
H13f 0BlackRock, Inc., with 8.6 million sharesSource2026-09-30
H13f name 0BlackRock, Inc.Source2026-09-30
H13f 1Vanguard Capital Management LLC, with 4.3 million sharesSource2026-09-30
H13f name 1Vanguard Capital Management LLCSource2026-09-30
H13f 2State Street Corp, with 2.9 million sharesSource2026-09-30
H13f name 2State Street CorpSource2026-09-30
H13f added47Source2026-09-30
H13f reduced35Source2026-09-30
Next form10-KSource2026-11-15
Next period endDec 31, 2026Source2026-11-12
Last period endSep 30, 2026Source2026-11-12
Next dueWednesday, March 31, 2027Source2026-11-15
Deadline days90Source2026-11-15
Cash out dayDec 6, 2026Source2026-11-12

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS